 |
市場調查報告書
商品編碼
2050634
癌症支持治療藥物市場：按藥物類別、適應症、分銷管道和地區分類Cancer Supportive Care Drugs Market, By Drug Class, By Indication, By Distribution Channel, By Geography |
||||||
價格
簡介目錄
預計到 2026 年，癌症支持治療藥物市場規模將達到 373.241 億美元，到 2033 年將達到 521.697 億美元。預計從 2026 年到 2033 年，該市場將以 4.9% 的複合年成長率成長。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 373.241億美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率： | 4.90% | 2033年市場規模預測： | 521.697億美元 |
支持性癌症治療是指為患有各種類型癌症的患者提供的護理。支持性治療旨在減輕患者的痛苦，並提高其生活品質。由於癌症具有侵襲性和病程長的特點，它是最常見的致命性慢性疾病之一，死亡率極高。癌症的高發病率、研發的進步以及生物製藥行業投資的不斷增加，預計將在預測期內推動市場成長。
市場動態
全球對癌症支持治療產品的需求不斷成長，預計將推動預測期內市場成長。例如，根據美國疾病管制與預防中心（CDC）的數據，截至2022年，美國醫院每年發生170萬例醫療相關感染（HAI），並導致9.9萬人死亡。在所有感染疾病中，尿道感染佔醫療相關感染疾病的比例最高，達32%，其次是手術部位感染（22%）、肺炎（15%）和血流感染疾病（14%）。
本次調查的主要特點
- 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
- 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
- 本研究根據以下參數對全球癌症支持護理產品市場的主要參與者進行了分析：公司概況、財務業績、產品系列、市場佔有率、分銷策略、主要發展、戰略和未來計劃。
- 透過利用本報告中的見解，企業負責人和經營團隊將能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
- 這份「全球癌症支持護理產品市場」報告的目標受群眾外包括行業內的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 相關人員可以透過利用全球癌症支援護理產品市場分析中使用的各種策略矩陣來簡化決策過程。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章：市場動態、監管與趨勢分析
- 市場動態
- 促進因素
- 抑制因子
- 市場吸引力分析
- 市場機遇
- 影響分析
- 財務概覽
- 產品發布
- 技術進步
- 監管趨勢
- 併購
第4章 全球癌症支持治療藥物市場：依藥物類別分類，2021-2033年
- 非類固醇消炎劑（NSAID）類
- 抗感染藥物
- 止吐藥
- 單株抗體
- 紅血球生成素促效劑
- 鴉片類鎮痛藥
- 雙磷酸鹽類藥物
- 顆粒細胞增生因子
第5章 全球癌症支持治療藥物市場：依適應症分類，2021-2033年
- 肺癌
- 乳癌
- 攝護腺癌
- 肝癌
- 膀胱癌
- 白血病
- 卵巢癌
- 惡性黑色素瘤
- 其他
第6章 全球癌症支持治療藥物市場：依通路分類，2021-2033年
- 醫院和藥房
- 零售藥房
- 網路藥房
第7章 全球癌症支持治療藥物市場：按地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
- 中東
- GCC
- 以色列
- 其他中東國家
- 非洲
- 北非
- 中非
- 南非
第8章 競爭情勢
- Amgen Inc
- Johnson & Johnson Private Ltd.
- Merck
- Novartis AG.
- Baxter International.
- Hoffmann-La Roche Ltd
- Fagron
- Teva Pharmaceutical Industries Ltd.
- G1 Therapeutics Inc.
- APR Applied Pharma Research SA
- Acacia Pharma
- EMD Serono
第9章
- 調查方法
- 關於本公司
簡介目錄
Product Code: CMI2013
Cancer Supportive Care Drugs Market is estimated to be valued at USD 37,324.1 Mn in 2026 and is expected to reach USD 52,169.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 4.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 37,324.1 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.90% | 2033 Value Projection: | USD 52,169.7 Mn |
Cancer supportive care is associated with care given to patients suffering from various types of cancer. Supportive care is intended for relieving the suffering of the patients and improving their quality of life. Cancer is one of the most prevalent fatal chronic disorders with a high mortality rate due to its invasive nature and prolonged duration of disease. The high prevalence of cancer, increasing research and development along with increasing investment in the biopharmaceutical industry is anticipated to drive the market growth during the forecast period.
Market Dynamics
The demand for the global cancer supportive care products is increasing and because of this it is expected to drive the market growth over the forecast period . For instance, In 2022, according to the Centers for Disease Control (CDC), Healthcare-associated infections (HAIs) in American hospitals are responsible for 1.7 million infections and 99,000 deaths occur per year. Out of all the infections, urinary tract infections occur up to 32% of all healthcare-acquired infections, followed by surgical site infections [22%], pneumonia [15%], and bloodstream infections[14%].
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the Global Cancer Supportive Care Products market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Amgen Inc., Johnson & Johnson Private Ltd., Merck, Novartis AG, Baxter International, Hoffmann-La Roche Ltd., Fagron, Teva Pharmaceutical Industries Ltd., G1 Therapeutics Inc., APR Applied Pharma Research s.a., Acacia Pharma, EMD Serono, and Kyowa Hakko Kirin Co., Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The Global Cancer Supportive Care Products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Cancer Supportive Care Products marke
Market Segmentation
- Global Cancer Supportive Care Products Market, By Drug Class (Revenue, USD Mn, 2021 - 2033)
- Nonsteroidal Anti- Inflammatory Drugs
- Anti-Infective
- Anti-Emetics
- Monoclonal Antibodies
- Erythropoietin Stimulating Agents
- Opioid Analgesics
- Bisphosphonates
- Granulocyte Colony Stimulating Factor
- Global Cancer Supportive Care Products Market, By Indication (Revenue, USD Mn, 2021 - 2033)
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Liver Cancer
- Bladder Cancer
- Leukemia
- Ovary Cancer
- Melanoma Cancer
- Others
- Global Cancer Supportive Care Products Market, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Compounding Pharmacies
- Global Cancer Supportive Care Products Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Amgen Inc.
- Johnson & Johnson Private Ltd.
- Merck
- Novartis AG
- Baxter International
- Hoffmann-La Roche Ltd.
- Fagron
- Teva Pharmaceutical Industries Ltd.
- G1 Therapeutics Inc.
- APR Applied Pharma Research s.a.
- Acacia Pharma
- EMD Serono
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Market Snapshot ,By Map
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Impact Analysis
- Financial Overview
- Product launch
- Technological Advancements
- Regulatory Scenario
- Mergers and Acquisitions
4. Global Cancer Supportive Care Products Market, By Drug Class, 2021 - 2033 (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Nonsteroidal Anti- Inflammatory Drugs Class
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Anti-Infective
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Anti-Emetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Erythropoietin Stimulating Agents
- Introduction
- Market Size and Forecast , and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Opioid Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Bisphosphonates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Granulocyte Colony Stimulating Factor
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
5. Global Cancer Supportive Care Products Market, By Indication, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Liver Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Bladder Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Leukemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Ovary Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Melanoma Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
6. Global Cancer Supportive Care Products Market, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Introduction
- Y-o-Y Growth Analysis, 2021 - 2033
- Market Share Analysis, 2026 and 2033 (%)
- Segments Trends
- Hospitals Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
7. Global Cancer Supportive Care Products Market, By Region, 2021- 2033, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs Class , 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs Class , 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs Class , 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs Class , 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs Class , 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Million)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Amgen Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Johnson & Johnson Private Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Merck
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis AG.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Baxter International.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Hoffmann-La Roche Ltd
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Fagron
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- G1 Therapeutics Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- APR Applied Pharma Research S.A
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Acacia Pharma
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- EMD Serono
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
9. Section
- Research Methodology
- About Us
